You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XPORT-MF-035

Showing 1 - 25 of 436
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

Recruiting
  • Myelofibrosis
  • Los Angeles, California
  • +41 more
Jan 30, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

Not yet recruiting
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 27, 2023

Acute Kidney Injury Trial in Worldwide (RMC-035, Placebo)

Recruiting
  • Acute Kidney Injury
  • Fort Wayne, Indiana
  • +28 more
Jan 17, 2023

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

Ankylosing Spondylitis Trial in Cayman Palms (ABY-035, Normal saline)

Terminated
  • Ankylosing Spondylitis
  • Glendale, Arizona
  • +46 more
Sep 21, 2022

Hematologic Malignancies Trial in Shanghai (GNC-035)

Recruiting
  • Hematologic Malignancies
  • Guiyang, Guizhou, China
  • +3 more
Jan 13, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Graves Disease Trial in Göteborg (MF course, Usual health care)

Recruiting
  • Graves Disease
  • MF course
  • Usual health care
  • Göteborg, Sweden
    Agneta Lindo
Nov 17, 2023

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

HIV Prevention Trial in Worldwide (Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche)

Completed
Has Results
  • HIV Prevention
  • Placebo rectal insert
  • +2 more
  • Birmingham, Alabama
  • +6 more
Jan 4, 2023

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Presbyopia Trial in Johns Creek (Lehfilcon A multlifocal contact lenses, Lotrafilcon B multifocal contact lenses, Hydrogen

Recruiting
  • Presbyopia
  • Lehfilcon A multlifocal contact lenses
  • +2 more
  • Johns Creek, Georgia
    Johns Creek Research Clinic
Mar 13, 2023

Healthcare Resource Utilization in Adult Myelofibrosis Through

Recruiting
  • Myelofibrosis
    • La Plata, Buenos Aires, Argentina
    • +62 more
    Feb 1, 2023

    Presbyopia Trial in Johns Creek (Lehfilcon A multifocal contact lenses, Lotrafilcon B multifocal contact lenses, Hydrogen

    Recruiting
    • Presbyopia
    • Lehfilcon A multifocal contact lenses
    • +2 more
    • Johns Creek, Georgia
      Alcon Study Site 07898
    Feb 3, 2023

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

    Terminated
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Larkspur, California
    • +2 more
    Nov 14, 2022

    Breast Cancer Trial in Guangzhou (GNC-035)

    Recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Dec 17, 2021

    Ruxolitinib in Patients With Myelofibrosis

    Completed
    • Myelofibrosis
    • (no location specified)
    Jun 5, 2022

    Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

    Recruiting
    • Sezary Syndrome
    • Mycosis Fungoides
    • Stanford, California
      Stanford Cancer Center
    Oct 19, 2022

    Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

    Active, not recruiting
    • Myelofibrosis
    • Antwerpen, Belgium
    • +11 more
    Aug 19, 2022

    Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)

    Not yet recruiting
    • Mycosis Fungoides
    • (no location specified)
    Apr 29, 2023

    Mycosis Fungoides Trial in Edmonton (Cemiplimab)

    Not yet recruiting
    • Mycosis Fungoides
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Sep 12, 2022

    Diagnostic Classifier for Cutaneous T-cell Lymphomas

    Recruiting
    • CTCL/ Mycosis Fungoides
    • Skin suction blistering and skin biopsies
    • Vienna, Austria
      Medical University of Vienna
    Apr 4, 2022